As of 4:00pm ET
| -0.11 / -2.81%|
The 3 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 42.00, with a high estimate of 44.00 and a low estimate of 9.00. The median estimate represents a +1,002.36% increase from the last price of 3.81.
The current consensus among 3 polled investment analysts is to Buy stock in aTyr Pharma Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.